Neovascular Clinical Trial
— PFCOfficial title:
Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters
NCT number | NCT01023698 |
Other study ID # | APEC0003 |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | April 2009 |
Est. completion date | April 2010 |
Verified date | May 2024 |
Source | Asociación para Evitar la Ceguera en México |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Is it possible to do a panretinal photocoagulation for proliferative diabetic retinopathy in a single session using low fluence parameters?
Status | Terminated |
Enrollment | 30 |
Est. completion date | April 2010 |
Est. primary completion date | April 2010 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - untreated Proliferative diabetic retinopathy Exclusion Criteria: - Previous photocoagulation |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Asociación para Evitar la Ceguera en México |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Stabilization of proliferative diabetic retinopathy | 2010 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00384631 -
Intravitreal Bevacizumab for Neovascular Glaucoma
|
N/A |